Predictive Technology Group, Inc.
Predictive Technology Group, Inc. (PRED) through its wholly owned subsidiary Predictive Therapeutics, Inc. revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. The Company has developed and/or acquired a number of proprietary technologies that open a window into the origin of human disease and the role that genes and their related proteins play in the disease’s onset and progression. PRED uses this information as the cornerstone in the development of new diagnostics that assess a person’s risk of disease and therapeutic products designed to effectively prevent and/or treat the disease.
|Reporting Status||Alternative Reporting Standard
Deregistered a/o Jan 04, 2011
|Latest Report||Nov 30, 2015 Quarterly Report|
|Fiscal Year End||8/31|
|OTC Marketplace||OTC Pink Current|
|SIC – Industry Classification||2835 – Diagnostic substances|
|Business Status||Development Stage Company a/o Sep 16, 2008|
|Incorporated In:||NV, USA|
|Year of Inc.||2005|
|Employees||10 a/o Jun 05, 2015|
|Mel Fergusen||Secretary, Treasurer|
5840 West Craig Road
Las Vegas, NV, 89130
716 Castro St.
Solana Beach, CA, 92075
Investor Relations Firm
3419 Virginia Beach Blvd.
Virginia Beach, VA, 23452
2020 General Booth Blvd, Unit 230
Va. Beach, VA 23454